Merck KGaA, Darmstadt, Germany webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference

Company invites individual and institutional investors, as well as advisors, to log-on to view the presentation

DARMSTADT, Germany, March 26, 2018 /CNW/ -- Merck KGaA, Darmstadt, Germany (XETRA: MRK.DE, OTC: MKKGY) a leading science and technology company, today announced that their March 22, 2018 presentation is now available for on-demand viewing in the dbVIC Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference.

LINK: https://tinyurl.com/dbvic03postpr

Merck KGaA, Darmstadt, Germany presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the virtual trade booth in the Exhibits section of the event.

Recent Company Highlights

• Merck Achieves Targets for 2017 – Dividend to Increase
• Merck Announced Positive Phase IIB Results for Evobrutinib in Relapsing Multiple Sclerosis
• Mavenclad (Cladribine Tablets) Receives First Approval in Latin America, following approval in the EU, Canada, Australia and Israel
• Merck Receives Patents for CRISPR Technology in U.S., Brazil, China, India, Japan, South Korea and Israel

About Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck KGaA, Darmstadt, Germany, generated sales of € 15.3 billion in 66 countries.

SOURCE Merck KGaA

Merck KGaA, Investor Relations, [email protected], [phone]